Light Sciences is using a spin-off strategy to revive light-activated therapy in a number of clinical areas, transforming a niche application into a platform technology. By Stephen Levin The recent gr
The one thing that cardiologists and cardiovascular device companies can agree on when it comes to vulnerable plaque (VP) is that it's too soon to know what they can agree on. But Guidant Corp. , p
Cost-effective biomaterials fill gaps in market When tissue is cut or damaged as a result of surgery, the body's wound healing response goes into high gear. Its attempt to join cut ends of tissue, how
A venture-backed Canadian biotechnology industry is in its infancy, but faced with hostile capital markets, start-ups need clear exit plans. Consolidation's already started. by Mary Stuart It is perha